CompletedNot Applicable

The ANCA Vasculitis Questionnaire (AAV-PRO©)

United States280 participantsStarted 2015-07

Plain-language summary

The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflammation in the small blood vessels leading to involvement of a range of organs and can suffer from ongoing disease activity or treatment side effects. Quality of life can be measured by patient reported outcome measures (PROMs).

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Registered in the Vasculitis Patient-Powered Research Network (V-PPRN) * Patients greater than 18 years of age * Diagnosis of ANCA-associated vasculitis including: Eosinophilic Granulomatosis with Polyangiitis (also called Churg-Strauss Syndrome), Granulomatosis with Polyangiitis (also called Wegener's granulomatosis or GPA), Microscopic Polyangiitis (MPA)

What they're measuring

Completion of AAV-PRO questionnaire.

Timeframe: 6 months

Trial details

NCT IDNCT02507024

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-12

View on ClinicalTrials.gov More Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) trials